Tatu Lajunen
- Pharmaceutical Science top 2%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
- Ophthalmology top 5%
- Retinal Diseases and Treatments 6
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 6
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 6
- Lipid Membrane Structure and Behavior 5
- Retinal Development and Disorders 4
-
- Gold and Silver Nanoparticles Synthesis and Applications 4
In The Last Decade
Tatu Lajunen
27 papers receiving 887 citations
Peers
Comparison fields: 5 of 84
- Pharmaceutical Science 162
- Biomaterials 292
- Ophthalmology 146
- Biomedical Engineering 307
- Molecular Biology 397
Countries citing papers authored by Tatu Lajunen
This map shows the geographic impact of Tatu Lajunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatu Lajunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatu Lajunen more than expected).
Fields of papers citing papers by Tatu Lajunen
This network shows the impact of papers produced by Tatu Lajunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatu Lajunen. The network helps show where Tatu Lajunen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tatu Lajunen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 32 | |
| 12 | 2022 | 33 | |
| 13 | 2022 | 21 | |
| 14 | 2022 | 12 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 86 | |
| 17 | 2018 | 20 | |
| 18 | 2018 | 57 | |
| 19 | 2016 | 80 | |
| 20 | 2015 | 115 |
About Tatu Lajunen
Tatu Lajunen is a scholar working on Biomaterials, Ophthalmology and Pharmaceutical Science, having authored 30 papers that have together received 898 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Retinal Diseases and Treatments (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoplatforms for cancer theranostics (6 papers), Lipid Membrane Structure and Behavior (5 papers), Retinal Development and Disorders (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). The work is most often cited by research in Pharmaceutical Science (162 citations), Biomaterials (292 citations) and Ophthalmology (146 citations). Tatu Lajunen has collaborated with scholars based in Finland, Japan and Russia. Frequent co-authors include Arto Urtti, Tapani Viitala, Lauri Viitala, Lasse Murtomäki, Leena-Stiina Kontturi, Marjo Yliperttula, Timo Laaksonen, Shirin Tavakoli, Marika Ruponen and Alex Bunker. Their work appears in journals such as Langmuir, Chemical Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.